Sign up
POM

POMDOCTOR LIMITED American Depositary Shares (NASDAQ: POM)

Healthcare · Pharmaceutical Retailers

——

Quote unavailable · The quote observation time could not be verified.

Set alert

The Quantellect read. Short interest is 22.38% of float with a 362.20% borrow fee. Descriptive summary of the data on this page, not a recommendation.

Relative valuationInsufficient comparable data

P/S 0.0× vs peer median 0.2×

MomentumNeutral

RSI (14) 53.3 (overbought above 70, oversold below 30)

Trend—

—

Short interest22.4% of float

FINRA settlement Oct 30, 2026

POM price chart

Price — · As of —

Open full chart →
Price details unavailable for this range.

Chart loads when this section enters view.

Text price and event history
6M plotted price range (ET)
Range6M
First date—
Last date—
Open—
High—
Low—
Close—
Volume—
Plotted bars0

Plotted OHLCV bars

No price bars are available for this range.

Event records

Event records load after the price chart.

Split-adjusted daily prices · Price as of —

Initial 6M price range summary
Range6M
First close—
Last close—
High—
Low—
Volume—
Open—
Previous close—
Day range—
52-week range
$0.07 – $5.57Through Nov 18, 2026
Volume—
Average volume (30 calendar days, 0 sessions)
—Through Nov 18, 2026
Market cap$4.28M
P/E (TTM)negative earnings —
Forward P/E—
EPS (TTM)stale vendor snapshot —
Dividend yielddata unavailable —
Beta (5-year monthly vs SPY)—

Price history

POM · NASDAQ · USD

Split-adjusted · volume in shares

Price history unavailable

Notable price movement

— · Notable price movement not available

Options flow

— · Options flow not available

Q Score

— · Q Score not available

Quantellect signals

Change since Nov 18

Insufficient data · Tide session Nov 18, 2026

Tide31Calm Tide—
Squeeze39Watch—
How the scores work →

How POM compares with its industry

Against 5 other US-listed Pharmaceutical Retailers stocks

Dot = rank among peers, low to high · tick = peer median · colour marks the top and bottom 10%

Valuation

Insufficient comparable data

  • Price/sales0.01×0.15×

    Not ranked: only 5 of 5 peers report it

  • Forward P/E—19.26×

    Not ranked: only 4 of 5 peers report it

  • Price/book—0.08×

    Not ranked: only 5 of 5 peers report it

Profitability

Not enough peers report profitability metrics for a group comparison.

  • Gross margin12.0%27.9%

    Not ranked: only 5 of 5 peers report it

  • Operating margin−125.9%−8.9%

    Not ranked: only 4 of 5 peers report it

  • Net margin−90.2%−4.6%

    Not ranked: only 5 of 5 peers report it

  • Return on equity0.0%−53.5%

    Not ranked: only 5 of 5 peers report it

Growth

Not enough peers report growth metrics for a group comparison.

  • Quarterly sales growth, year over year6.0%21.4%

    Not ranked: only 5 of 5 peers report it

  • 5-year sales growth rate—−52.1%

    Not ranked: only 1 of 5 peers report it

Balance sheet

Not enough peers report balance sheet metrics for a group comparison.

  • Current ratio0.481.10

    Not ranked: only 3 of 5 peers report it

  • Debt/equity (total borrowings)—0.02

    Not ranked: only 1 of 5 peers report it

Momentum

Not enough peers report returns for a group comparison.

  • 1-year return−97.9%−32.0%

    Not ranked: only 2 of 5 peers report it

  • 6-month return−28.3%−37.2%

    Not ranked: only 3 of 5 peers report it

  • 3-month return+57.8%−3.3%

    Not ranked: only 3 of 5 peers report it

Compared with 5 other US-listed Pharmaceutical Retailers stocks · fundamentals as of Nov 18, 2026 · prices as of Nov 18, 2026

Upcoming events

— · Upcoming events not available

Analyst consensus

— · Analyst consensus not available

Earnings history

— · Earnings history not available

Smart-money activity

— · Smart-money activity not available

All smart-money activity →

News and press releases

News and press releases are not available.

All POM news →

Company profile

Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products. The company in involved in internet hospital and pharmaceutical supply chain, connecting users, pharmacies, suppliers,

CEO
Mr. Zhenyang Shi
Headquarters
Guangzhou, China
Employees
165
IPO date
Oct 8, 2025
Sector
Healthcare
Industry
Pharmaceutical Retailers
Website
7lk.com

Data sources: exchange quotes delayed 15 minutes, FINRA short interest, SEC filings, OPRA options data and third-party analyst data. Education only. Nothing on this page is a recommendation to buy or sell a security.